SHELL ASSET MANAGEMENT CO - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$379
+3.6%
4,233
-1.6%
0.02%
+14.3%
Q2 2023$366
+2.2%
4,300
-0.6%
0.01%
-6.7%
Q1 2023$358
+5.0%
4,325
-0.3%
0.02%0.0%
Q4 2022$341
-99.9%
4,340
-18.0%
0.02%0.0%
Q3 2022$392,000
-9.9%
5,292
-20.6%
0.02%
+15.4%
Q2 2022$435,000
+3.6%
6,668
+0.3%
0.01%
+30.0%
Q1 2022$420,000
+3.7%
6,650
-12.8%
0.01%
+25.0%
Q4 2021$405,000
-24.6%
7,628
+0.3%
0.01%
-33.3%
Q3 2021$537,000
+1.5%
7,608
-4.2%
0.01%
+20.0%
Q2 2021$529,000
-36.5%
7,938
+5.7%
0.01%
-41.2%
Q1 2021$833,000
-7.2%
7,508
-0.7%
0.02%
-10.5%
Q4 2020$898,000
+36.3%
7,5580.0%0.02%
+26.7%
Q3 2020$659,000
-2.7%
7,5580.0%0.02%
-11.8%
Q2 2020$677,000
-10.9%
7,558
-0.9%
0.02%
-19.0%
Q1 2020$760,000
-14.5%
7,625
-1.5%
0.02%
+10.5%
Q4 2019$889,000
-10.7%
7,741
-2.0%
0.02%
-17.4%
Q3 2019$996,000
+4.0%
7,896
-0.9%
0.02%
+9.5%
Q2 2019$958,000
+34.4%
7,964
-2.2%
0.02%
+31.2%
Q1 2019$713,000
-12.5%
8,1460.0%0.02%
-20.0%
Q4 2018$815,000
-19.6%
8,146
-7.9%
0.02%0.0%
Q3 2018$1,014,0008,8460.02%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders